The potential influence of inflammation and insulin resistance on the pathogenesis and treatment of atherosclerosis-related complications in type 2 diabetes

J Clin Endocrinol Metab. 2003 Jun;88(6):2422-9. doi: 10.1210/jc.2003-030178.
No abstract available

Publication types

  • Review

MeSH terms

  • Arteriosclerosis / drug therapy*
  • Arteriosclerosis / etiology*
  • Cardiovascular Agents / therapeutic use
  • Diabetes Mellitus, Type 2*
  • Diabetic Angiopathies / drug therapy*
  • Diabetic Angiopathies / etiology*
  • Humans
  • Hypoglycemic Agents / therapeutic use
  • Inflammation / complications*
  • Insulin Resistance*

Substances

  • Cardiovascular Agents
  • Hypoglycemic Agents